Aptevo Therapeutics Inc

NASDAQ:APVO   4:00:00 PM EDT
3.09
-0.03 (-0.96%)
7:54:46 PM EDT: $3.09 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Aptevo Therapeutics Inc Stock, NASDAQ:APVO

2401 4th Avenue, Suite 1050, Seattle, Washington 98121
United States of America
Phone: +1.206.838.0500
Number of Employees: 54

Description

Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded on February 22, 2016 and is headquartered in Seattle, WA.